Back to top
more

AtriCure (ATRC)

(Delayed Data from NSDQ)

$23.17 USD

23.17
380,567

+0.56 (2.48%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $23.16 -0.01 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (140 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ATRC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for AtriCure, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 137 121 119 244 82
Receivables 53 43 33 23 28
Notes Receivable 0 0 0 0 0
Inventories 68 46 39 35 29
Other Current Assets 9 5 5 4 4
Total Current Assets 266 215 196 307 143
Net Property & Equipment 42 39 31 28 33
Investments & Advances 0 52 104 14 13
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 299 274 278 363 365
Deposits & Other Assets 2 2 1 0 1
Total Assets 614 585 615 715 558
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 27 20 19 13 15
Current Portion Long-Term Debt 3 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 45 33 36 28 33
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 5 2 8 2
Total Current Liabilities 75 58 56 49 50
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 61 66 60 53 60
Non-Current Capital Leases 8 0 10 11 12
Other Non-Current Liabilities 1 1 1 187 186
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 148 129 132 302 311
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 824 787 765 742 530
Retained Earnings -357 -327 -280 -330 -282
Other Equity -1 -4 -1 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 466 457 484 412 247
Total Liabilities & Shareholder's Equity 614 585 615 715 558
Total Common Equity 466 457 484 412 247
Shares Outstanding 47.40 46.50 45.90 45.00 39.50
Book Value Per Share 9.83 9.82 10.54 9.16 6.26

Fiscal Year End for AtriCure, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 137 133 127 136
Receivables NA 53 52 48 46
Notes Receivable NA 0 0 0 0
Inventories NA 68 62 55 49
Other Current Assets NA 9 6 7 8
Total Current Assets NA 266 253 238 238
Net Property & Equipment NA 42 41 41 40
Investments & Advances NA 0 0 8 26
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 299 300 302 273
Deposits & Other Assets NA 2 2 2 2
Total Assets NA 614 600 594 583
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 27 25 24 24
Current Portion Long-Term Debt NA 3 21 16 11
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 45 37 32 28
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 75 83 71 62
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 61 50 47 52
Non-Current Capital Leases NA 8 8 9 9
Other Non-Current Liabilities NA 1 1 1
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 148 137 132 128
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 824 812 803 791
Retained Earnings NA -357 -347 -338 -333
Other Equity NA -1 -2 -3 -3
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 466 463 462 455
Total Liabilities & Shareholder's Equity NA 614 600 594 583
Total Common Equity 0 466 463 462 455
Shares Outstanding 48.30 47.40 47.40 47.30 47.20
Book Value Per Share 0.00 9.83 9.76 9.78 9.64